This ADC product is comprised of an anti-TMEFF2 monoclonal antibody conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF
* VAT and and shipping costs not included. Errors and price changes excepted